E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/21/2006 in the Prospect News Biotech Daily.

Bear Stearns rates Schering Plough at underperform

Schering Plough Corp. was reiterated at underperform with a $14 fair value price by Bear Stearns analyst John Boris on news that the generic Flonase discount erodes to 42% from 28%. There is also risk to the analyst's 2007 Nasonex estimate of $580 million. Shares of the Kenilworth, N.J., pharmaceutical company were down 3 cents, or 0.16%, at $19.30 on volume of 5,486,600 shares versus the three-month running average of 7,202,080 shares. (NYSE: SGP)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.